Search clinical trials for: YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)

Total 124 results

Bayer

Completed

Efficacy and Safety Oral Contraceptive Study

Contraception
Bayer

Completed

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

Acne Vulgaris

United States
Bayer

Completed

Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

Acne Vulgaris

United States
Bayer

Completed

Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

Contraceptives, Oral

Netherlands
Bayer

Completed

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)

Contraception

Netherlands
Bayer

Completed

YAZ Post-marketing Surveillance in Japan

Dysmenorrhea

Japan
Bayer

Completed

Regulatory Post Marketing Surveillance Study on YAZ

Contraception | Acne | Premenstrual Syndrome

Korea, Republic of
Bayer

Completed

Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

Contraception

Netherlands, Canada, Germany
Bayer

Completed

YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

Contraception

China
Bayer

Withdrawn

To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea

Dysmenorrhea
Bayer

Completed

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

Premenstrual Dysphoric Disorder ( PMDD)

China
Bayer

Completed

Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate

Contraception

Germany
Bayer

Completed

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin)

Contraception

Germany
Estetra

Completed

E4/DRSP Ovarian Function Inhibition Study

Prevention of Pregnancy

Netherlands
Bayer

Completed

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

Contraception | Ovulation Inhibition | Contraceptives, Oral

United States
Bayer

Completed

Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea

Dysmenorrhea

Japan
Woman's
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Completed

Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism (BEYAZ-PCOS)

Polycystic Ovary Syndrome

United States
Duramed Research

Completed

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

Dysmenorrhea

United States
Estetra

Completed

"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"

Contraception | Liver Metabolism | Hemostasis Parameter

Netherlands
Autoimmune Technologies, LLC

Completed

Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects

Influenza

United States
Estetra

Completed

E4/DRSP Single and Multiple Dose PK and Early QT Study

Contraception
Duramed Research

Completed

A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.

Contraception

United States
Bayer

Completed

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

Healthy

Germany
Organon and Co

Completed

A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

Contraception
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)

Healthy
Bayer

Completed

Comparative Trial in Hormone Withdrawal Associated Symptoms

Oral Contraceptive

Switzerland, Portugal, Chile, Italy, Korea, Republic of, Venezuela, Philippines, Colombia, Thailand, Argentina, Germany, Russian Federation, United Kingdom, Czech Republic
Duramed Research

Completed

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

Dysmenorrhea

United States
MedImmune LLC

Completed

Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults

Healthy Volunteer

United Kingdom
Novartis Pharmaceuticals

Completed

A First-in-Human Study of CEE321 in Adult Subjects

Atopic Dermatitis

United States, Japan
Estetra

Completed

Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers

Contraception
University of Geneva, Switzerland
University of Lausanne

Recruiting

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies (AMA)

Periodontal Diseases | Pharmacokinetics | Antibiotics

Switzerland
Chulalongkorn University

Completed

Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone

Premenstrual Syndrome

Thailand
Estetra
PRA Health Sciences

Completed

E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study

Contraception

Belgium
Estetra
PRA Health Sciences

Completed

E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study

Contraception

United States, Canada
Tibotec Pharmaceuticals, Ireland

Withdrawn

PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.

HIV Infections

Netherlands
Teva Pharmaceuticals USA

Completed

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting

Healthy

United States
Bayer

Completed

Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.

Healthy
Otsuka Pharmaceutical Development & Commercialization...
Bill and Melinda Gates Foundation

Completed

A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis

Pulmonary TB

South Africa
MacroGenics

Completed

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Cervical Cancer | Hematologic Neoplasms | Ovarian Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Small-cell Lung Cancer | TNBC - Triple-Negative Breast Cancer | HER2-positive Advanced Solid Tumors

Hong Kong, United States, Thailand, Australia, Spain, Bulgaria, Poland, Ukraine
Centre Hospitalier Universitaire, Amiens
Merck Serono International SA

Completed

May Metformin be Used in Renal Failure?

Renal Disorder Associated With Type II Diabetes Mellitus

France
Pfizer
Halozyme Therapeutics

Terminated

Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase

Healthy | Hypercholesterolemia

Belgium
Ardea Biosciences, Inc.
Quotient Clinical

Completed

IVIVR Assessing PK Parameters Used to Establish Bioequivalence

Healthy

United Kingdom
Lexicon Pharmaceuticals

Completed

Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Centre Hospitalier Universitaire de Saint Etienne

Recruiting

A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty (PRADO)

Arthropathy of Hip

France
Laboratorios Andromaco S.A.

Completed

Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

Bioequivalence

Chile
Global Alliance for TB Drug Development

Completed

A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary

United States
University of Michigan

Terminated

OPTIMA-TBI Pilot Study (OPTIMA)

Mild Traumatic Brain Injury

United States
Johane Allard
Canadian Institutes of Health Research (CIHR); American College of Gastroenterology

Completed

Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)

Non-alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

Canada
Grace Lim, MD, MS
National Institute of Mental Health (NIMH)

Recruiting

Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery

Pain, Postoperative | Depression, Postpartum

United States
Estetra

Completed

Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents

Safety

Estonia, Finland, Georgia, Latvia, Poland, Sweden

3

Subscribe